Podocalyxin enhances the adherence of cells to platelets |
| |
| Authors: | S. Larrucea N. Butta R. B. Rodriguez S. Alonso-Martin E. G. Arias-Salgado M. S. Ayuso R. Parrilla |
| |
| Affiliation: | (1) Department of Physiopathology, Centro de Investigaciones Biológicas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain;(2) Centre for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain;(3) Present address: Endocrinology and Diabetes Section, Research Unit, Hospital de Cruces, Baracaldo, Vizcaya, Spain |
| |
| Abstract: | Podocalyxin (PODXL) is a mucin protein of the CD34 family expressed in kidney glomerular podocytes, vascular endothelium, progenitor bone marrow and tumor cells. It is assumed that PODXL plays an anti-adherent role in kidney podocytes. CHO cells stably expressing human PODXL (CHO-PODXL) or human tumor cells (Tera-1) inherently expressing PODXL showed increased adherence to platelets. The adherence of cells was inhibited (70%) by blockers of platelet P-selectin, prevented by the soluble ectodomain of human PODXL (PODXL-Δ) or by the arginine-glycine-aspartate (RGDS) peptide and partially impeded by inhibition of integrin αVβ3/αVβ5, suggesting a coordinated action of P-selectin and integrins. Colocalization of platelet P-selectin and PODXL expressed on CHO cells was demonstrated by confocal immunofluorescence. No adherence to platelets was observed when PODXL was expressed in glycomutant CHO cells deficient in sialic acid. Received 14 August 2007; received after revision 12 September 2007; accepted 13 September 2007 |
| |
| Keywords: | Podocalyxin platelets adhesion aggregation Tera-1 |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
